Moderna Inc (MRNA)
Gross profit margin
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Gross profit | US$ in thousands | -792,000 | 12,435,000 | 15,098,000 | 604,584 | -49,720 |
| Revenue | US$ in thousands | 6,775,000 | 19,263,000 | 18,471,000 | 803,000 | 60,000 |
| Gross profit margin | -11.69% | 64.55% | 81.74% | 75.29% | -82.87% |
December 31, 2023 calculation
Gross profit margin = Gross profit ÷ Revenue
= $-792,000K ÷ $6,775,000K
= -11.69%
Moderna Inc's gross profit margin has exhibited a declining trend over the past five years, as depicted in the data provided. The gross profit margin stood at 31.47% as of December 31, 2023, significantly lower than the levels observed in the preceding years. Specifically, there was a notable decrease from 71.88% in 2022, 85.83% in 2021, and 99.01% in 2020. The gross profit margin was at its peak at 100.00% in 2019.
This declining trend in the gross profit margin could suggest various factors such as changes in the cost of goods sold, pricing strategies, or operational inefficiencies impacting the company's ability to generate profits from its core business activities. It is essential for investors and stakeholders to further investigate the underlying reasons behind this trend to assess the company's financial performance accurately and make informed decisions.
Peer comparison
Dec 31, 2023